JPH0672101B2 - 水添麦角アルカロイドとヘパリンからなる医薬 - Google Patents

水添麦角アルカロイドとヘパリンからなる医薬

Info

Publication number
JPH0672101B2
JPH0672101B2 JP58233457A JP23345783A JPH0672101B2 JP H0672101 B2 JPH0672101 B2 JP H0672101B2 JP 58233457 A JP58233457 A JP 58233457A JP 23345783 A JP23345783 A JP 23345783A JP H0672101 B2 JPH0672101 B2 JP H0672101B2
Authority
JP
Japan
Prior art keywords
component
molecular weight
pharmaceutical composition
heparin
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58233457A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59116222A (ja
Inventor
ハンス・ビユ−ルマン
デイ−タ−・ベルツエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS59116222A publication Critical patent/JPS59116222A/ja
Publication of JPH0672101B2 publication Critical patent/JPH0672101B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58233457A 1982-12-10 1983-12-09 水添麦角アルカロイドとヘパリンからなる医薬 Expired - Lifetime JPH0672101B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE32456956 1982-12-10
DE3245695.6 1982-12-10
DE3245695 1982-12-10

Publications (2)

Publication Number Publication Date
JPS59116222A JPS59116222A (ja) 1984-07-05
JPH0672101B2 true JPH0672101B2 (ja) 1994-09-14

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58233457A Expired - Lifetime JPH0672101B2 (ja) 1982-12-10 1983-12-09 水添麦角アルカロイドとヘパリンからなる医薬

Country Status (25)

Country Link
JP (1) JPH0672101B2 (enExample)
AT (1) AT382514B (enExample)
AU (1) AU570658B2 (enExample)
BE (1) BE898356A (enExample)
CA (1) CA1224416A (enExample)
CH (1) CH656533A5 (enExample)
CY (1) CY1509A (enExample)
DD (1) DD215469B3 (enExample)
DK (1) DK162475C (enExample)
FR (1) FR2537435B1 (enExample)
GB (1) GB2131691B (enExample)
GR (1) GR79745B (enExample)
HK (1) HK23290A (enExample)
HU (1) HU190513B (enExample)
IE (1) IE56366B1 (enExample)
IL (1) IL70406A (enExample)
IT (1) IT1172368B (enExample)
LU (1) LU85127A1 (enExample)
NL (1) NL8304221A (enExample)
NZ (1) NZ206523A (enExample)
PH (1) PH23451A (enExample)
PT (1) PT77803B (enExample)
SE (1) SE468973B (enExample)
SG (1) SG53989G (enExample)
ZA (1) ZA839200B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792L (sv) 1984-06-11
FR2537435B1 (fr) 1987-03-20
SG53989G (en) 1989-12-29
IL70406A0 (en) 1984-03-30
HU190513B (en) 1986-09-29
DD215469B3 (de) 1988-03-09
AT382514B (de) 1987-03-10
CH656533A5 (de) 1986-07-15
IT8349456A1 (it) 1985-06-07
PT77803A (en) 1984-01-01
LU85127A1 (fr) 1984-10-22
DK162475B (da) 1991-11-04
PH23451A (en) 1989-08-07
GB2131691B (en) 1986-12-03
IT1172368B (it) 1987-06-18
SE468973B (sv) 1993-04-26
AU2222183A (en) 1984-06-14
AU570658B2 (en) 1988-03-24
ATA428483A (de) 1986-08-15
NL8304221A (nl) 1984-07-02
ZA839200B (en) 1985-07-31
CY1509A (en) 1990-08-03
DK565783A (da) 1984-06-11
DD215469A5 (de) 1984-11-14
GB8332653D0 (en) 1984-01-11
HUT34124A (en) 1985-02-28
HK23290A (en) 1990-04-06
CA1224416A (en) 1987-07-21
DK565783D0 (da) 1983-12-08
FR2537435A1 (fr) 1984-06-15
IE832896L (en) 1984-06-10
GR79745B (enExample) 1984-10-31
NZ206523A (en) 1987-04-30
IE56366B1 (en) 1991-07-03
JPS59116222A (ja) 1984-07-05
BE898356A (fr) 1984-06-04
DK162475C (da) 1992-05-11
IT8349456A0 (it) 1983-12-07
IL70406A (en) 1988-08-31
GB2131691A (en) 1984-06-27
SE8306792D0 (sv) 1983-12-08
PT77803B (en) 1986-04-17

Similar Documents

Publication Publication Date Title
EP0444492B1 (en) Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment
DE69019774T2 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
JPH05505618A (ja) 相乗的治療用組成物及び方法
DE60029340T2 (de) Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran
KR20000029975A (ko) 히스타민수용체길항제의배합물을사용한상부기도알레르기반응의치료
US20220072011A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
TW201700105A (zh) 玻尿酸之用途及疼痛抑制用醫藥組成物
DE69511448T2 (de) Verwendung von Phosphorsäurediester-Verbindungen zur Unterdrückung von Krebsmetastasen in der Leber
KR20060113737A (ko) 약제학적 조성물
US3228834A (en) Pharmaceutical diluent compositions
EP3597198B1 (en) Composition for treating joint diseases and kit including same
AU608268B2 (en) Nasal solutions
JPH0672101B2 (ja) 水添麦角アルカロイドとヘパリンからなる医薬
KR100342367B1 (ko) 녹내장치료제및안압강하제
EP0393909A1 (en) Composition
KR20190037500A (ko) 히알루론산과 마그네슘을 포함하는 골관절염 치료를 위한 안정한 액상 조성물
SK164695A3 (en) Use of ropivacaine in the manufacture of a pharmaceutical agent with analgetic effect with minimal motor blockade
US5561154A (en) Treatment of acute urinary retention
US6818662B2 (en) Pharmaceutical composition
NZ212097A (en) Parenteral pharmaceutical composition comprising metoclopramide (4-amino-5-chloro-n-((2-diethylamino) ethyl)-2-methoxybenzamide) and optionally sodium metabisulphite
CN114364401A (zh) 防止含有对二羟硼基苯丙氨酸的注射液剂的析出的方法
EP0365363A1 (en) Parenteral formulations of 1-diphenylmethyl-4-[(2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl]piperazine
CN114423458A (zh) 含有对二羟硼基苯丙氨酸的注射液剂
KR100738021B1 (ko) 은행엽 엑스 고농도 함유 주사제
JPH0753388A (ja) 骨代謝改善剤